Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Canonical Url: www.lavoisier.eu/books/life-sciences/biotechnology-et-genetic-engineering-reviews-volume-21/harding/description-9781898298915
Permalink: www.lavoisier.eu/books/note.asp?ouvrage=1905491

Description

Biotechnology & genetic engineering reviews, volume 21

Author: HARDING S E

Cover of the book Biotechnology & genetic engineering reviews, volume 21

Subjects of Biotechnology & genetic engineering reviews, volume 21

128.40 €

In stock: 24 hours delivery!

Add to cartAdd to cart
Publication date: 11-2004
Language: English
390 p. Hardback

Description of Biotechnology & genetic engineering reviews, volume 21

A well-established hardcover review series with one new volume published each year. Each volume contains approximately 15 original, major review articles covering important developments in industrial, agricultural, and medical applications of biotechnology (wide sense), with particular emphasis on the genetic manipulation of the organisms concerned.

Contents of Biotechnology & genetic engineering reviews, volume 21

Part 1: Techniques: 1. Power ultrasound – a means to promote and control crystallization in biotechnology. 2. Discovery and applications of small molecule probes for studying biological processes. Part 2: Microbial & Cellular Biotechnology: 3. Vaginal microbicides for the prevention of HIV transmission. 4. Cell adhesion molecules in plants and animals. 5. Bone marrow stromal stem cells for repairing the skeleton. Part 3: Pharmaceutical Technology: 6. Polymeric delivery systems for biopharmaceuticals. 7. Biotechnological aspects of transport across human skin. Part 4: Protein Biotechnology: 8. Inhibitors of amyloid aggregation: technologies for the discovery of novel lead compounds. Part 5: Plant Biotechnology: 9. Starch retrogradation. 10. Re-designing lignin for industry and agriculture. Part 6: Economics and Safety Issues: 11. Beyond Bayh–Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business. 12. The liabilities from regulating gene flow in plant-made pharmaceuticals. 13. Safety testing and regulation of genetically engineered foods. 14. Design of safe and biologically contained transgenic plants: tools and technologies for controlled transgene flow and expression. Index.